266360-62-7 Usage
General Description
D-2,6-Difluorophenyl-alanine is a synthetic amino acid derivative that contains two fluorine atoms attached to a phenylalanine molecule. It is commonly used as a building block for the synthesis of new pharmaceutical compounds due to its unique structural properties. This chemical has been studied for its potential use in drug development, particularly in the creation of novel therapeutic agents for various medical conditions. D-2,6-Difluorophenyl-alanine has also been investigated for its potential role in the study of protein-protein interactions and the development of targeted drug delivery systems. Overall, this chemical compound shows promise for its potential applications in the pharmaceutical and biotechnology industries.
Check Digit Verification of cas no
The CAS Registry Mumber 266360-62-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,6,3,6 and 0 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 266360-62:
(8*2)+(7*6)+(6*6)+(5*3)+(4*6)+(3*0)+(2*6)+(1*2)=147
147 % 10 = 7
So 266360-62-7 is a valid CAS Registry Number.
InChI:InChI=1/C9H9F2NO2/c10-6-2-1-3-7(11)5(6)4-8(12)9(13)14/h1-3,8H,4,12H2,(H,13,14)/t8-/m1/s1
266360-62-7Relevant articles and documents
HALOALKYL CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS
-
Page/Page column 45-46, (2008/06/13)
The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.
HALOALKYL CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS
-
Page/Page column 56, (2008/06/13)
The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.
AMIDINO COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS
-
Page/Page column 40, (2010/02/09)
The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsins B, K, L, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceu
